Zumutor Biologics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 24

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $7.3M

  • Investors
  • 12

Zumutor Biologics General Information

Description

Operator of an immuno-oncology company intended to offer targeted cell therapeutics. The company develops diverse human antibody libraries to identify novel Immunotherapies and improved monoclonal antibodies and targets certain receptors that block NK cell inhibitory signals and allow NK cell activation to generate a potent immune response, enabling clinicians to access novel immunotherapies that target innate immunity and regulate the tumor microenvironment.

Contact Information

Website
www.zumutor.com
Formerly Known As
Theramyt Novobiologics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • CIC Cambridge Campus
  • 1 Broadway
  • Cambridge, MA 02142
  • United States
+1 (806)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • CIC Cambridge Campus
  • 1 Broadway
  • Cambridge, MA 02142
  • United States
+1 (806)

Zumutor Biologics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zumutor Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series A) 13-Jun-2026 $7.3M Completed Clinical Trials - Phase 1
8. Later Stage VC (Series A) 23-Feb-2026 Completed Clinical Trials - Phase 1
7. Accelerator/Incubator Completed Clinical Trials - Phase 1
6. Later Stage VC (Series A) 08-Apr-2025 Completed Clinical Trials - Phase 1
5. Later Stage VC (Series A) 31-Dec-2021 Completed Pre-Clinical Trials
4. Later Stage VC (Series A2) 12-Nov-2019 Completed Pre-Clinical Trials
3. Later Stage VC (Series A1) 30-May-2018 Completed Startup
2. Early Stage VC (Series A) 01-Jan-2015 $5.6M $11.6M Completed Startup
1. Seed Round 11-Oct-2013 $6M $6M Completed Startup
To view Zumutor Biologics’s complete valuation and funding history, request access »

Zumutor Biologics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A5
Series A4
Series A3
Series A2
Series A1
Series A 18,924,405 $0.001000 8% $0.29 $0.29 1x $0.29 9.33%
Seed 24,955,233 $0.001000 8% $0.18 $0.18 1x $0.18 12.31%
To view Zumutor Biologics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Zumutor Biologics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of an immuno-oncology company intended to offer targeted cell therapeutics. The company develops diverse human
Drug Discovery
Cambridge, MA
24 As of 2026

South San Francisco, CA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zumutor Biologics Competitors (43)

One of Zumutor Biologics’s 43 competitors is ArsenalBio, a Venture Capital-Backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ArsenalBio Venture Capital-Backed South San Francisco, CA
Nkarta Therapeutics Formerly VC-backed South San Francisco, CA
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
Kite Pharma Formerly VC-backed Santa Monica, CA
Adicet Bio Formerly VC-backed Boston, MA
You’re viewing 5 of 43 competitors. Get the full list »

Zumutor Biologics Patents

Zumutor Biologics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2020202832-A Non-fucosylated protein and methods Pending 10-Jul-2020
AU-2020222891-A1 Anti-clec2d antibodies and methods of use thereof Active 11-Feb-2019
AU-2020222891-B2 Anti-clec2d antibodies and methods of use thereof Active 11-Feb-2019
CA-3129818-A1 Anti-clec2d antibodies and methods of use thereof Pending 11-Feb-2019
EP-3924385-A1 Anti-clec2d antibodies and methods of use thereof Pending 11-Feb-2019 C07K16/2851
To view Zumutor Biologics’s complete patent history, request access »

Zumutor Biologics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zumutor Biologics Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Premji Invest Growth/Expansion Minority
Angel (individual) Minority
3iPartners Venture Capital Minority
Startfresh Ventures Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Zumutor Biologics FAQs

  • When was Zumutor Biologics founded?

    Zumutor Biologics was founded in 2013.

  • Where is Zumutor Biologics headquartered?

    Zumutor Biologics is headquartered in Cambridge, MA.

  • What is the size of Zumutor Biologics?

    Zumutor Biologics has 24 total employees.

  • What industry is Zumutor Biologics in?

    Zumutor Biologics’s primary industry is Drug Discovery.

  • Is Zumutor Biologics a private or public company?

    Zumutor Biologics is a Private company.

  • What is the current valuation of Zumutor Biologics?

    The current valuation of Zumutor Biologics is .

  • What is Zumutor Biologics’s current revenue?

    The current revenue for Zumutor Biologics is .

  • How much funding has Zumutor Biologics raised over time?

    Zumutor Biologics has raised $40.9M.

  • Who are Zumutor Biologics’s investors?

    , Premji Invest, , 3iPartners, and Startfresh Ventures are 5 of 12 investors who have invested in Zumutor Biologics.

  • Who are Zumutor Biologics’s competitors?

    ArsenalBio, Nkarta Therapeutics, CytomX Therapeutics, Kite Pharma, and Adicet Bio are some of the 43 competitors of Zumutor Biologics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process